Plasma procalcitonin and the risk of cardiovascular events and death: A prospective population-based study

Journal of Internal Medicine

Volumn 272, Issue 5, 2012, Pages 484-491

  Schiopu, A ^a   Hedblad, B ^a   Engstrom G ^a   Struck, J ^b   Morgenthaler, N G ^b   Melander, O ^a  

^a LUND UNIVERSITY   (Sweden)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

C reactive protein; Cardiovascular risk factors; Inflammation; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; PROCALCITONIN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84867913767     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02548.x     Document Type: Article

References (29)

1. Khot UN, Khot MB, Bajzer CT et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290: 898-904.
2. Erren M, Reinecke H, Junker R et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-63.
3. Melander O, Newton-Cheh C, Almgren P et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49-57.
4. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512-25.
5. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
6. Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-8.
7. Linscheid P, Seboek D, Nylen ES et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-84.
8. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32: 1715-21.
9. Abbasi A, Corpeleijn E, Postmus D et al. Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocrinol Metab 2010; 95: E26-31.
10. Kafkas N, Venetsanou K, Patsilinakos S et al. Procalcitonin in acute myocardial infarction. Acute Card Care 2008; 10: 30-6.
11. Ataoglu HE, Yilmaz F, Uzunhasan I et al. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res 2010; 38: 52-61.
12. Kelly D, Khan SQ, Dhillon O et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers 2010; 15: 325-31.
13. Sinning CR, Sinning JM, Schulz A et al. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J 2011; 75: 1184-91.
14. Morgenthaler NG, Struck J, Fischer-Schulz C, Bergmann A. Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 2002; 48: 788-90.
15. Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 2002; 48: 263-70.
16. Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005; 257: 430-7.
17. Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B. Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis 2005; 179: 325-31.
18. Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L. Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke 2001; 32: 1098-103.
19. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30(Suppl 1): S30-4.
20. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006; 47: C19-31.
21. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109: 1955-9.
22. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001; 18: 79-87.
23. Saemann MD, Poglitsch M, Kopecky C, Haidinger M, Horl WH, Weichhart T. The versatility of HDL: a crucial anti-inflammatory regulator. Eur J Clin Invest 2010; 40: 1131-43.
24. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002; 33: 2744-9.
25. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-65.
26. Miyakis S, Georgakopoulos P, Kiagia M et al. Serial serum procalcitonin changes in the prognosis of acute stroke. Clin Chim Acta 2004; 350: 237-9.
27. Di Napoli M, Schwaninger M, Cappelli R et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005; 36: 1316-29.
28. Zia E, Hedblad B, Pessah-Rasmussen H, Berglund G, Janzon L, Engstrom G. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke 2007; 38: 2681-5.
29. Saremi A, Anderson RJ, Luo P et al. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis 2009; 203: 610-4.